Drug Type Tetraspecific antibody |
Synonyms umizortamig |
Mechanism 4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists), CD3ε inhibitors(CD3e molecule inhibitors), EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists) + [1] |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |